dr. A. Diepstra

pathologist and post-doc researcher


  1. 2019
  2. 2018
  3. Schrader, A. M. R., Jansen, P. M., Willemze, R., Vermeer, M. H., Cleton-Jansen, A-M., Somers, S. F., ... Vermaat, J. S. P. (2018). High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood, 131(18), 2086-2089. https://doi.org/10.1182/blood-2017-12-822817
  4. Viganò, E., Gunawardana, J., Mottok, A., Van Tol, T., Mak, K., Chan, F. C., ... Steidl, C. (2018). Somatic IL4R Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. Blood, 131(18), 2036-2046. https://doi.org/10.1182/blood-2017-09-808907
  5. 2017
  6. Somers, S., Jansen, P., Veelken, H., Vermeer, M., Kraan, W., Schrader, A-R., ... Vermaat, J. (2017). High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors? Blood, 130.
  7. 2016
  8. Abdul Razak, F. R., Diepstra, A., Jong, D., Koerts, J., Rutgers, B., Kluiver, J., ... Berg, van den, A. (2016). Mutations in CD58 and MYB in Hodgkin Lymphoma. Haematologica, 101, 4-5. [P031].
Previous 1 2 3 Next

ID: 197725